Giuseppe Giaccone Joins Georgetown Lombardi Comprehensive Cancer Center

Posted in News Release

WASHINGTON — Internationally recognized lung cancer expert Giuseppe Giaccone, MD, PhD, has joined Georgetown Lombardi Comprehensive Cancer Center, a part of MedStar Georgetown University Hospital and Georgetown University Medical Center.

Giaccone serves as associate director for clinical research at Georgetown Lombardi Comprehensive Cancer Center, co-leader of its experimental therapeutics program and director of the lung cancer program. He is also director of clinical research for the MedStar Georgetown Cancer Network, a clinical affiliation between MedStar Health and Georgetown Lombardi that combines and expands the strengths of clinical care and research to significantly improve patient access to cancer services. His joint appointment with Georgetown Lombardi and MedStar Health enhances the current expansion of cancer clinical services in the Washington, D.C. metropolitan area.

Giaccone previously was chief of the National Cancer Institute’s Center for Cancer Research’s Medical Oncology Branch. He is credited with helping transform the NCI branch through reorganization of its clinical infrastructure and recruitment of strong faculty.

“Dr. Giaccone has a tremendous reputation for building and leading world-class clinical and research programs — an asset that holds particular value as we grow the MedStar Georgetown Cancer Network,” says Louis M. Weiner, M.D., director of Georgetown Lombardi.  “His contributions to Georgetown Lombardi and MedStar Health will allow the Network to expand its clinical research base, providing greater access for our patients to novel clinical trials and state-of-the-art treatments.”

Giaccone says his drive for nurturing new programs is grounded in his personal research pursuits.

“Over the past several years, my main interest has been early clinical research — bridging the gap between laboratory and clinical research — and applying cutting-edge technologies in that effort,” says Giaccone, who is also a recognized expert in developing early stage clinical trials. “I am particularly interested in bringing new anticancer agents from the laboratory to the clinic in an effort to improve the treatment of lung cancer and other solid tumors.”

In addition to his experience studying new anticancer agents, Giaccone is an expert in the biology and treatment of lung cancer, thymomas and other solid tumors.

A native of Italy, Giaccone received his MD from the University Torino Medical School in Torino, Italy, and his PhD from Vrije Universiteit in Amsterdam, The Netherlands. He conducted his residency at University Medical School in Torino and completed his internship at the Institute of Oncology in Torino.

Giaccone serves on the editorial boards of many medical and scientific journals, including Clinical Cancer Research, Frontiers in Oncology, Annals of Oncology and Investigational New Drugs. He has received numerous awards for his research and service in the field of oncology. Among them, he received the NDDO Honorary Award (2011), NCI Director’s Award (2010), and the Ihde Memorial Lecture (2009). A frequent guest lecturer and prolific contributor to scientific and medical publications, Giaccone has served in many organizational leadership roles including member of the board of the EORTC (European Organization for Research and Treatment of Cancer) and chair of its lung cancer group, chair of the lung cancer intramural program at NCI, and president of the TAT (Targeted Anticancer Therapies) series of symposia.

About MedStar Georgetown University Hospital
MedStar Georgetown University Hospitalis a not-for-profit, acute-care teaching and research hospital with 609 beds located in Northwest Washington, D.C. Founded in the Jesuit principle of cura personalis—caring for the whole person—MedStar Georgetown is committed to offering a variety of innovative diagnostic and treatment options within a trusting and compassionate environment.

MedStar Georgetown’s centers of excellence include neurosciences, transplant, cancer and gastroenterology. Along with Magnet® nurses, internationally recognized physicians, advanced research and cutting-edge technologies, MedStar Georgetown’s healthcare professionals have a reputation for medical excellence and leadership. MedStar Georgetown University Hospital—Knowledge and Compassion…Focused on You.

About MedStar Health
MedStar Health combines the best aspects of academic medicine, research and innovation with a complete spectrum of clinical services to advance patient care.  As the largest healthcare provider in Maryland and the Washington, D.C., region, MedStar’s 10 hospitals, the MedStar Health Research Institute and a comprehensive scope of health-related organizations are recognized regionally and nationally for excellence in medical care. MedStar has one of the largest graduate medical education programs in the country, training more than 1,100 medical residents annually, and is the medical education and clinical partner of Georgetown University.  MedStar Health is a $4.5 billion not-for-profit, regional healthcare system based in Columbia, Maryland, and one of the largest employers in the region.  Its almost 30,000 associates and 6,000 affiliated physicians all support MedStar Health’s Patient First philosophy that combines care, compassion and clinical excellence with an emphasis on customer service. 

About Georgetown Lombardi Comprehensive Cancer Center
Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center and MedStar Georgetown University Hospital, seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic and clinical research, patient care, community education and outreach, and the training of cancer specialists of the future. Georgetown Lombardi is one of only 41 comprehensive cancer centers in the nation, as designated by the National Cancer Institute (grant #P30 CA051008), and the only one in the Washington, DC area. For more information, go to

About Georgetown University Medical Center
Georgetown University Medical Center is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through MedStar Health). GUMC’s mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis — or “care of the whole person.” The Medical Center includes the School of Medicine and the School of Nursing & Health Studies, both nationally ranked; Georgetown Lombardi Comprehensive Cancer Center, designated as a comprehensive cancer center by the National Cancer Institute; and the Biomedical Graduate Research Organization (BGRO), which accounts for the majority of externally funded research at GUMC including a Clinical Translation and Science Award from the National Institutes of Health.